MarketPulse
I

$IQV

11 articles found
10 positive
0 negative
1 neutral
Investing.comInvesting.com··David Wagner

Eight Undervalued Stocks Offer Up to 85% Upside as Market Rally Leaves Laggards Behind

Eight fundamentally sound stocks trade 25-85% below fair value estimates, offering significant upside while the S&P 500 and NASDAQ reach records.
AMDIQVSONsemiconductor stocksundervalued stocks
The Motley FoolThe Motley Fool··Eric Volkman

Eli Lilly's Weight-Loss Drug Stumbles Out of Gate, Stock Drops Nearly 4%

Eli Lilly's new weight-loss drug Foundayo recorded just 3,707 prescriptions in week two, trailing Novo Nordisk's Wegovy by over 400%, triggering a 4% stock decline.
LLYNVOIQVstock declineFDA approval
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Clinical Trial Management Systems Market Surges to $4.2B by 2030

Clinical trial management systems market expands from $2.25B in 2025 to $4.2B by 2030, driven by cloud adoption, AI integration, and decentralized trial models.
ORCLORCLpDIQVVEEVcloud-based platformsdecentralized trials
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

AI Clinical Trial Tool Market to Hit $2.76B by 2030 as Protocol Optimization Accelerates

AI clinical trial feasibility market expands from $0.83B (2025) to $2.76B by 2030 at 27.3% CAGR, driven by precision medicine and decentralized trials.
IQVVEEVTEMprecision medicinepredictive analytics
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Clinical Trial Data Visualization Market to Double by 2030 Amid AI Surge

Clinical trial data visualization market projected to grow from $0.89B (2025) to $1.82B (2030) at 15.4% CAGR, driven by AI adoption and decentralized trials.
ORCLORCLpDTMOIQVICLRcloud-based solutionsdecentralized trials
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

AI Clinical Trial Market Poised to Triple to $8.5B by 2030

AI clinical trial solutions market expanding from $3B to $8.5B by 2030, driven by patient recruitment optimization, cloud platforms, and regulatory automation.
IBMIQVdecentralized clinical trialscloud-based platforms
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Clinical Trials Tech Market Set to Surge 59% to $81.46B by 2030

Clinical trials tech market projected to grow 59% from $51.15B (2025) to $81.46B (2030) at 9.8% CAGR, driven by AI, decentralized models, and digital transformation.
ORCLORCLpDIBMIQVICLRclinical trialsAI adoption
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Drug Development Services Market Set to Double to $50B by 2030

Drug development services market projected to reach $50.26B by 2030 from $28.09B in 2025, driven by AI adoption, personalized medicine, and emerging market expansion.
CRLIQVLZAGYLHWUXAYregulatory complianceclinical trials
BenzingaBenzinga··Vandana Singh

Charles River Labs to Divest CDMO and Discovery Units in Strategic Restructuring

Charles River Labs divests CDMO and discovery units to GI Partners and IQVIA, reducing revenue but boosting profitability and raising 2026 earnings guidance.
CRLIQVearnings guidancedivestiture
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider

Global Pharmacovigilance Market to Expand Threefold to $24.69B by 2035

Pharmacovigilance market projected to grow threefold from $8.91B (2025) to $24.69B (2035), driven by stricter regulations and rising adverse drug reactions globally.
ORCLORCLpDACNIQVVEEV+1regulatory compliancerisk management
GlobeNewswire Inc.GlobeNewswire Inc.··Towards Healthcare

Clinical Trial Software Market to Nearly Triple to $34.15B by 2035

Clinical trial software market projected to nearly triple to $34.15B by 2035, driven by pharmaceutical industry's digital transformation and increased adoption of AI-enabled solutions.
ORCLORCLpDTMOIQVVEEV+1regulatory compliancecloud-based solutions